Explore 8 Overlooked Biotech Careers in 2025
The global biotech market stands at $1.55 trillion in 2024 and experts predict it will reach $4.25 trillion by 2033 . Most people picture scientists in lab coats when they think of biotech, but the field offers many more opportunities that go way beyond the...
Pharma Interview Questions: What Top Recruiters Actually Ask
Pharmaceutical interview questions have grown more complex as the biopharmaceutical industry expands at a strong 7% growth rate between 2022 and 2027. Our team has seen this growth create fierce competition for qualified candidates, especially when you have an ongoing shortage of experienced GMP-trained personnel in the...
Why the Pharma Job Market Is Shifting (And What It Means for Your Career)
The pharma job market shows signs of a most important change. New job postings related to future of work dropped by 0.70% in Q2 2024 compared to the previous quarter. This change comes at an unexpected time as the pharmaceutical market’s revenue soared to $1,115...
Why Pharmaceutical Trends in 2025 Are Not What Experts Predicted
The pharmaceutical sector’s performance has surprised many experts. The PwC pharma index delivered just 7.6% returns to shareholders since 2018, while the S&P 500 achieved 15%. This gap grew more pronounced last year when pharma returns reached 13.9% compared to the broader market’s 28.7%. Today’s...
The Hidden Truth About Diversity in Clinical Trials: Expert Insights
Racial and ethnic minorities make up 39% of the U.S. population, but their representation in clinical trials ranges from a mere 2% to 16%. This significant gap in clinical trial diversity raises valid concerns about medical research’s effectiveness across population groups. The numbers paint a...
The Future of Pharma: What Industry Leaders Say About DEI hiring in 2025
The future of pharma shines through a compelling story about clinical trial transformation. FDA-approved trial participants were 84% white in 2014, but this number dropped by a lot to 50% by 2023. This change shows our industry’s new approach to diversity. The pharmaceutical industry now experiences unprecedented...
Why AI Pricing Optimization Actually Works in Pharma [Real Results]
Pharmaceutical companies that use AI pricing optimization have achieved a soaring win with their bidding success rates jumping by 30%. This breakthrough comes at a crucial time when the industry faces intense pricing pressures and complex market dynamics. The pharmaceutical industry’s pricing strategy landscape continues...
Why Pharma Collaboration is Reshaping Disease Modeling in 2025
Drug development faces a significant challenge: 28% of medications leave the US market because of unexpected heart-related side effects. This stark reality, combined with 400 million people worldwide affected by rare diseases, makes pharmaceutical collaboration more vital than ever. Pharmaceutical companies are reshaping their approach...
Building Your GMP Dream Team: Essential Staffing Guide for Pharma Facilities
The FDA under CFR Title 21 monitors GMP violations that can lead to severe consequences. Companies face product recalls, hefty fines, and maybe even jail time. These strict standards ensure pharmaceutical products maintain their identity, quality, strength, and purity. The success of cGMP manufacturing depends...
What is Pharma 4.0? Why Drug Makers are Investing Now
A shocking 70% of organizational transformations fail because of poor communication and lack of buy-in. This fact makes it even more significant for today’s pharmaceutical industry to understand Pharma 4.0 and how to implement it properly. Traditional pharmaceutical manufacturing has always depended on manual processes....